tirzepatide and naltrexone Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity Tirzepatide Weight Loss Corpus Christi

Un estudio de caso y control (80 embarazos afectados por DTN y 409 controles) en mujeres de EE.UU

Tirzepatide currently has two FDA-approved indications, neither of which includes binge eating disorder

Sustained Weight Reduction With Once-Weekly Semaglutide: Results From a Real-World Retrospective Cohort Study in the United States (Scope 24 Months)

For someone at 240 pounds, that gap represents an additional 14 to 15 pounds of fat loss

Sderberg L, Johannesson M, Nygren P et al (2023) Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimers Disease